“…EVs present in the uterine lumen on Day 13 of pregnancy, delivered in vitro to both epithelial endometrial (Day 12 of the estrous cycle) and trophoblast cells (PTr2 cell line; origin—Day 12 filamentous conceptus), altered the expression of thousands of genes in recipient cells. Enrichment analysis indicated that these genes are involved in immune system regulation (CCL family, e.g., CCL1 , CCL2 , and CXCL family, e.g., CXCL10 , CXLCL11 ), cellular processes such as migration (MMPs, e.g., MMP9 , MMP11 , and TIMPs, e.g., TIMP1 and TIMP3 ) and adhesion (integrin α genes, e.g., ITGA2 , ITGA5 , integrin β genes, e.g., ITGB3 , ITGB5 , cadherin genes, e.g., CDH1 , CDH3 ), as well as EV secretion and uptake ( TSG101 and MX1 ) (Hua et al, 2022). Other studies have shown that uterine EVs derived from Day 15 pregnant pigs inhibit migration and proliferation of immortalized Day 12 porcine trophoblast cells (Hu et al, 2022).…”